Chemical Formula: C11H14ClN

benalfocin

C11H14ClN (195.0814714)

D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine

C11H14ClN (195.0814714)

4-(2-chlorophenyl)piperidine

C11H14ClN (195.0814714)

2,3,4,5-TETRAHYDRO-1H-1,5-METHANO-3-BENZAZEPINE HYDROCHLORIDE

C11H14ClN (195.0814714)

1H-3-Benzazepine, 8-chloro-2,3,4,5-tetrahydro-1-Methyl-, (1S)-

C11H14ClN (195.0814714)

4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride

C11H14ClN (195.0814714)

4-Phenyl-1,2,3,6-tetrahydropyridinehydrochloride

C11H14ClN (195.0814714)

1-(4-Chlorobenzyl)pyrrolidine

C11H14ClN (195.0814714)

3-(2-Chlorobenzyl)pyrrolidine

C11H14ClN (195.0814714)

(4-CHLORO-6-(METHYLTHIO)PYRIMIDIN-5-YL)METHANAMINE

C11H14ClN (195.0814714)

4-(4-Chlorophenyl)piperidine

C11H14ClN (195.0814714)

1-[1-(4-Chlorophenyl)cyclobutyl]methanamine

C11H14ClN (195.0814714)

Lorcaserin

C11H14ClN (195.0814714)

A - Alimentary tract and metabolism > A08 - Antiobesity preparations, excl. diet products > A08A - Antiobesity preparations, excl. diet products > A08AA - Centrally acting antiobesity products C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist

pargyline hydrochloride

C11H14ClN (195.0814714)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor

3-(4-Chlorophenyl)piperidine

C11H14ClN (195.0814714)

C11H14ClN

C11H14ClN (195.0814714)

1-[1-(3-Chlorophenyl)cyclobutyl]methanamine

C11H14ClN (195.0814714)

4-(3-Chlorophenyl)piperidine

C11H14ClN (195.0814714)

SK&F 86466

C11H14ClN (195.0814714)

D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists